Services

Histology

Pharmacology

Medical Device Testing

In Vitro Screening

Animal Model Development

Custom Assay Development

Vivarium Rental

Toxicology

Species

Non-human Primates

Dogs

Mini-pigs / Pigs

Rabbits

Mice

Rats

Sheep

Guinea Pigs

Hamsters

Other Species

Therapeutic Areas

Oncology

Immunology & Inflammation

Neurology / CNS

Cardiovascular

Dermatology & Wound Healing

Metabolism

Gastroenterology

Hepatology

Pulmonology

Infectious Diseases & Sepsis

Musculoskeletal

Nephrology & Urology

Capabilities

GLP / IND-Enabling Studies

Small and Large Animal Housing

Bioanalytical Platforms

About

News

Contact

Career

Request a Quote

Logo
☰
  • Services ⌄
    • Histology
    • Pharmacology
    • Medical Device Testing
    • In Vitro Screening
    • Animal Model Development
    • Custom Assay Development
    • Vivarium Rental
    • Toxicology
  • Species ⌄
    • Non-human Primates
    • Dogs
    • Mini-pigs / Pigs
    • Rabbits
    • Mice
    • Rats
    • Sheep
    • Guinea Pigs
    • Hamsters
    • Other Species
  • Therapeutic Areas ⌄
    • Oncology
    • Immunology & Inflammation
    • Neurology / CNS
    • Cardiovascular
    • Dermatology & Wound Healing
    • Metabolism
    • Gastroenterology
    • Hepatology
    • Pulmonology
    • Infectious Diseases & Sepsis
    • Musculoskeletal
    • Nephrology & Urology
  • Capabilities ⌄
    • GLP / IND-Enabling Studies
    • Small and Large Animal Housing
    • Bioanalytical Platforms
  • About ⌄
    • News
  • Contact ⌄
    • Career
    • Request a Quote

Genentech Sues Pfizer Over Herceptin Biosimilar Patents

  • Post author:Sam
  • Post published:November 21, 2017
  • Post category:Drug Industry Daily

Genentech filed a lawsuit aiming to stop Pfizer’s proposed Herceptin biosimilar from reaching the market — asking the court to compensate for losses in sales should the copy launch before…

Continue ReadingGenentech Sues Pfizer Over Herceptin Biosimilar Patents

EMA Adopts Guideline on Developing Treatments for Autism

  • Post author:Sam
  • Post published:November 21, 2017
  • Post category:Drug Industry Daily

The European Medicines Agency adopted a guideline for sponsors developing new products for autism spectrum disorder, providing recommendations on diagnostic criteria, target populations and clinical trial design. Source: Drug Industry…

Continue ReadingEMA Adopts Guideline on Developing Treatments for Autism

FDA Outlines Guidance for Generic Abuse-Deterrent Opioid Pills

  • Post author:Sam
  • Post published:November 21, 2017
  • Post category:Drug Industry Daily

The FDA finalized guidance for manufacturers looking to produce generic versions of opioid painkillers with abuse-deterrent labeling, as a part of the agency’s push to lower overall exposure to opioids…

Continue ReadingFDA Outlines Guidance for Generic Abuse-Deterrent Opioid Pills

FDA Flags Drugmaking Problems at Chinese Company

  • Post author:Sam
  • Post published:November 20, 2017
  • Post category:Drug Industry Daily

The FDA cited a Chinese medical instrument company for problems in the manufacturing of drugs included in its production. Source: Drug Industry Daily

Continue ReadingFDA Flags Drugmaking Problems at Chinese Company

New York Indicts Pharmacist, Pharmacy Owner for Stealing from Medicaid

  • Post author:Sam
  • Post published:November 20, 2017
  • Post category:Drug Industry Daily

New York’s attorney general indicted a pharmacy owner, pharmacist and three pharmacies for defrauding Medicaid of $3 million in reimbursements for drugs that were never dispensed. Source: Drug Industry Daily

Continue ReadingNew York Indicts Pharmacist, Pharmacy Owner for Stealing from Medicaid

EMA Expands Safety Guidance for Developing Anticancer Drugs

  • Post author:Sam
  • Post published:November 20, 2017
  • Post category:Drug Industry Daily

The European Medicines Agency adopted the fifth revision of its substantive guideline covering all stages of oncology drug development, expanding upon the previous version’s section on safety data. Source: Drug…

Continue ReadingEMA Expands Safety Guidance for Developing Anticancer Drugs

The EMA Gets a New Home: Amsterdam

  • Post author:Sam
  • Post published:November 20, 2017
  • Post category:Drug Industry Daily

The European Union landed on Amsterdam as the new home for the European Medicines Agency headquarters, following three rounds of voting and a tiebreaker against Milan. The agency hopes to…

Continue ReadingThe EMA Gets a New Home: Amsterdam

Store Club Card Not a Valid Drugmaking Tool, FDA Warns Compounder

  • Post author:Sam
  • Post published:November 17, 2017
  • Post category:Drug Industry Daily

A worker at an Idaho compounding pharmacy used “a worn plastic store club card” to scoop a powdered drug into empty gelatin capsules, in violation of federal regulations, the FDA…

Continue ReadingStore Club Card Not a Valid Drugmaking Tool, FDA Warns Compounder

Insurance Broker Claims Lilly Trained Nurse Educators to Push Its Drugs

  • Post author:Sam
  • Post published:November 17, 2017
  • Post category:Drug Industry Daily

A newly unsealed lawsuit filed this summer alleged Eli Lilly ran an illegal kickback operation with two healthcare marketing firms. Source: Drug Industry Daily

Continue ReadingInsurance Broker Claims Lilly Trained Nurse Educators to Push Its Drugs

Judge Denies Compounder’s Motion to Dismiss Allergan’s False Advertising Complaint

  • Post author:Sam
  • Post published:November 17, 2017
  • Post category:Drug Industry Daily

A federal judge refused to dismiss a false advertising lawsuit filed by Allergan against drug compounder Imprimis Pharmaceuticals concerning its dry-eye drug Klarity, meant to compete with Allergan’s Restasis. Source:…

Continue ReadingJudge Denies Compounder’s Motion to Dismiss Allergan’s False Advertising Complaint
  • Go to the previous page
  • 1
  • …
  • 287
  • 288
  • 289
  • 290
  • 291
  • 292
  • 293
  • …
  • 385
  • Go to the next page

Stay Connected

Keep up with the latest news & insights.

Contact Us

Phone:
+1 858-605-5882
Fax:
+1 858-605-5916
Email:
info@biolegacyresearch.com
Mail:

6042 Cornerstone Court W

Suite E

San Diego, CA 92121

Social:
© 2025 BioLegacy Research. All rights reserved.